Citalopram for Agitation in Alzheimer’s Disease
Condition(s):Alzheimer’s Disease; AgitationLast Updated:June 27, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s Disease; AgitationLast Updated:June 27, 2014Completed
Condition(s):PTSDLast Updated:May 7, 2019Completed
Condition(s):Anxiety DisorderLast Updated:February 11, 2011Unknown status
Condition(s):HealthyLast Updated:December 10, 2012Completed
Condition(s):PMSLast Updated:June 6, 2014Terminated
Condition(s):Healthy Young and Elderly VolunteersLast Updated:March 11, 2020Terminated
Condition(s):MDD; Citalopram; Major Depressive DisorderLast Updated:September 12, 2017Completed
Condition(s):HealthyLast Updated:October 24, 2017Completed
Condition(s):HealthyLast Updated:October 24, 2017Completed
Condition(s):Dysthymic DisorderLast Updated:November 11, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.